↓ Skip to main content

The Walnuts and Healthy Aging Study (WAHA): Protocol for a Nutritional Intervention Trial with Walnuts on Brain Aging

Overview of attention for article published in Frontiers in Aging Neuroscience, January 2017
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (93rd percentile)
  • High Attention Score compared to outputs of the same age and source (91st percentile)

Mentioned by

news
3 news outlets
twitter
15 X users
facebook
1 Facebook page

Readers on

mendeley
269 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
The Walnuts and Healthy Aging Study (WAHA): Protocol for a Nutritional Intervention Trial with Walnuts on Brain Aging
Published in
Frontiers in Aging Neuroscience, January 2017
DOI 10.3389/fnagi.2016.00333
Pubmed ID
Authors

Sujatha Rajaram, Cinta Valls-Pedret, Montserrat Cofán, Joan Sabaté, Mercè Serra-Mir, Ana M. Pérez-Heras, Adam Arechiga, Ricardo P. Casaroli-Marano, Socorro Alforja, Aleix Sala-Vila, Mónica Doménech, Irene Roth, Tania M. Freitas-Simoes, Carlos Calvo, Anna López-Illamola, Ella Haddad, Edward Bitok, Natalie Kazzi, Lynnley Huey, Joseph Fan, Emilio Ros

Abstract

Introduction: An unwanted consequence of population aging is the growing number of elderly at risk of neurodegenerative disorders, including dementia and macular degeneration. As nutritional and behavioral changes can delay disease progression, we designed the Walnuts and Healthy Aging (WAHA) study, a two-center, randomized, 2-year clinical trial conducted in free-living, cognitively healthy elderly men and women. Our interest in exploring the role of walnuts in maintaining cognitive and retinal health is based on extensive evidence supporting their cardio-protective and vascular health effects, which are linked to bioactive components, such as n-3 fatty acids and polyphenols. Methods: The primary aim of WAHA is to examine the effects of ingesting walnuts daily for 2 years on cognitive function and retinal health, assessed with a battery of neuropsychological tests and optical coherence tomography, respectively. All participants followed their habitual diet, adding walnuts at 15% of energy (≈30-60 g/day) (walnut group) or abstaining from walnuts (control group). Secondary outcomes include changes in adiposity, blood pressure, and serum and urinary biomarkers in all participants and brain magnetic resonance imaging in a subset. Results: From May 2012 to May 2014, 708 participants (mean age 69 years, 68% women) were randomized. The study ended in May 2016 with a 90% retention rate. Discussion: The results of WAHA might provide high-level evidence of the benefit of regular walnut consumption in delaying the onset of age-related cognitive impairment and retinal pathology. The findings should translate into public health policy and sound recommendations to the general population (ClinicalTrials.gov identifier NCT01634841).

X Demographics

X Demographics

The data shown below were collected from the profiles of 15 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 269 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
United States 1 <1%
Philippines 1 <1%
Brazil 1 <1%
Unknown 266 99%

Demographic breakdown

Readers by professional status Count As %
Student > Master 43 16%
Student > Bachelor 42 16%
Researcher 25 9%
Student > Ph. D. Student 23 9%
Student > Postgraduate 13 5%
Other 49 18%
Unknown 74 28%
Readers by discipline Count As %
Medicine and Dentistry 53 20%
Nursing and Health Professions 29 11%
Biochemistry, Genetics and Molecular Biology 19 7%
Agricultural and Biological Sciences 19 7%
Psychology 13 5%
Other 50 19%
Unknown 86 32%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 28. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 17 May 2023.
All research outputs
#1,267,221
of 23,727,139 outputs
Outputs from Frontiers in Aging Neuroscience
#291
of 5,006 outputs
Outputs of similar age
#28,070
of 425,086 outputs
Outputs of similar age from Frontiers in Aging Neuroscience
#9
of 94 outputs
Altmetric has tracked 23,727,139 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 94th percentile: it's in the top 10% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 5,006 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 13.6. This one has done particularly well, scoring higher than 94% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 425,086 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 93% of its contemporaries.
We're also able to compare this research output to 94 others from the same source and published within six weeks on either side of this one. This one has done particularly well, scoring higher than 91% of its contemporaries.